Ergoteles’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-166,172
| Closed | -$1.02M | – | 1254 |
|
|
2023
Q1 | $1.02M | Buy |
166,172
+26,759
| +19% | +$163K | 0.04% | 496 |
|
|
2022
Q4 | $891K | Buy |
139,413
+94,276
| +209% | +$602K | 0.03% | 497 |
|
|
2022
Q3 | $432K | Buy |
+45,137
| New | +$432K | 0.02% | 813 |
|
|
2022
Q2 | – | Sell |
-125,229
| Closed | -$2.09M | – | 1812 |
|
|
2022
Q1 | $2.09M | Buy |
125,229
+10,695
| +9% | +$178K | 0.08% | 252 |
|
|
2021
Q4 | $2.19M | Buy |
114,534
+2,700
| +2% | +$51.5K | 0.09% | 240 |
|
|
2021
Q3 | $2.76M | Buy |
111,834
+65,966
| +144% | +$1.63M | 0.1% | 220 |
|
|
2021
Q2 | $1.19M | Sell |
45,868
-153,379
| -77% | -$3.99M | 0.03% | 458 |
|
|
2021
Q1 | $6.31M | Buy |
199,247
+95,578
| +92% | +$3.03M | 0.2% | 138 |
|
|
2020
Q4 | $4.81M | Buy |
103,669
+40,317
| +64% | +$1.87M | 0.16% | 144 |
|
|
2020
Q3 | $2.09M | Buy |
+63,352
| New | +$2.09M | 0.28% | 65 |
|